NCT05451212 2025-11-10Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia GravisCabaletta BioPhase 1 Completed7 enrolled
NCT01960855 2021-08-24A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic TherapyAbbViePhase 2 Completed276 enrolled 14 charts